SCHEMBL29607604

SCHEMBL29607604

O=C(O)COc1cccc(N2CCC(=O)NC2=O)c1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 9/20 0.57
▸ CRBN Q96SW2 9/20 0.57
▸ ITGB3 P05106 3/20 0.48
▸ ITGA2B P08514 3/20 0.48
▸ LMNA P02545 1/20 0.47
▸ PLA2G10 O15496 1/20 0.46
▸ ALOX15 P16050 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PTPN7 P35236 1/20 0.41
▸ CPT2 P23786 1/20 0.41
▸ CPT1A P50416 1/20 0.41
▸ CPT1B Q92523 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23120540 1.00 DDB1 (0.57) DDB1CRBNITGB3ITGA2BLMNA
SCHEMBL23120479 0.85 DDB1 (0.56) DDB1CRBNITGB3ITGA2BALOX15
SCHEMBL25079571 0.83 TPSAB1 (0.51) DDB1CRBNMEN1MAPTKMT2A
SCHEMBL30257675 0.83 DDB1 (0.64) DDB1CRBNLMNAHSD17B10MEN1
SCHEMBL23120866 0.81 CRBN (0.58) DDB1CRBNHSD17B10MEN1MAPT
SCHEMBL29606941 0.81 CRBN (0.58) DDB1CRBNHSD17B10MEN1MAPT
SCHEMBL23120685 0.80 CRBN (0.57) DDB1CRBNHSD17B10MEN1MAPT
SCHEMBL25247627 0.79 CRBN (0.46) DDB1CRBN
SCHEMBL24777183 0.79 DDB1 (0.51) DDB1CRBNALOX15HSD17B10TSHR
SCHEMBL25259486 0.79 HSD17B10 (0.42) DDB1CRBNALOX15HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120092003-A CDK protein degrading agents, pharmaceutical compositions and therapeutic uses 拜欧斯瑞克斯公司 2025-06-03 — — CN disclosed
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 — — WO disclosed
CN-114521196-A Bifunctional group degradation agent and use method thereof 诺华股份有限公司 2022-05-20 — — CN disclosed
Send feedback